Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B

NCT03128736 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

175

Enrollment

OTHER

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Esomeprazole group
DRUG: Dexlansoprazole group

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital